Evaluating ginkgetin from <i>Ginkgo biloba</i> as a novel agent for sleep promotion through molecular docking and <i>in vivo</i> studies.

Ginkgetin, derived from <i>G. biloba</i>, shows promising potential as a novel therapeutic agent for sleep disorders, supported by its strong affinity to key receptor sites and its efficacy in modulating sleep architecture <i>in vivo</i>. These findings contribute to the expanding evidence base for the therapeutic use of <i>G. biloba</i> in sleep promotion and underscore the need for further research to elucidate the mechanisms and clinical applicability of ginkgetin in sleep disorder treatment.